Opportunity Information: Apply for RFA MH 24 322

The National Institutes of Health (NIH) is offering a cooperative agreement (U24; clinical trial not allowed) to establish and operate a Data Coordinating Center (DCC) for a research initiative focused on identifying preteen suicide risk and protective factors. The opportunity is listed as RFA-MH-24-322 under CFDA 93.242 and sits within the health funding category. The overarching purpose is not to run clinical trials, but to support a coordinated, data-driven effort that improves how the field understands and predicts suicide-related outcomes in preteens, including how risk emerges, changes over time, and potentially becomes actionable for prevention.

A central emphasis of the initiative is the development of models of preteen suicide risk that go beyond broad, static risk indicators. NIH is looking for research that can explain "risk states" and how those states transition into observable risk behaviors, including self-harm and suicide attempts. In practical terms, this points to work that can characterize patterns, trajectories, and near-term warning signs, and that can distinguish between underlying vulnerability and periods of acute or escalating risk. The intent is to support modeling approaches that can connect data to real-world clinical and public health decision-making, rather than simply cataloging correlates.

Another major goal is the identification of protective factors, both proximal and distal, that could be strengthened or enhanced to change a child's risk trajectory. Proximal protective factors are those that may buffer risk in the near term (for example, immediate supports, coping resources, or family and school-based protective conditions), while distal protective factors may shape longer-term resilience and developmental pathways. The opportunity explicitly highlights the need to find protective factors that are not only measurable, but also potentially modifiable, meaning they could serve as levers for prevention strategies rather than just descriptive variables.

The initiative also aims to pinpoint intervention targets and the timing of intervention, along with scalable assessment approaches that have clinical utility. This reflects a priority for tools and measurement strategies that can be used in real settings such as pediatric clinics, schools, community programs, and other youth-serving systems. "Scalable assessment" implies approaches that can be implemented broadly and efficiently, while "clinical utility" signals an expectation that outputs should help characterize risk and protective factors in a way that supports screening, monitoring, triage, referral, or other prevention-related actions. The DCC role in this context is typically to ensure that data collected across participating projects are harmonized, well-managed, quality-controlled, and made usable for advanced analyses that address these goals.

This funding opportunity uses a cooperative agreement mechanism, which usually means NIH expects substantial programmatic involvement during the award. Compared with a standard research grant, a U24 often carries stronger expectations around coordination, shared infrastructure, data standards, governance processes, and responsiveness to NIH program priorities. A DCC funded through this mechanism commonly provides leadership on data governance, common data elements, documentation, secure data transfer, database design, analytic support, and collaboration facilitation across the broader research consortium.

Eligible applicants are broad and include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations (other than small businesses); and small businesses. The notice also calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, the opportunity clearly excludes non-domestic (non-U.S.) entities, non-domestic components of U.S. organizations, and foreign components as defined in NIH policy; foreign organizations are not eligible, and foreign components are not allowed.

Key administrative details provided include an original closing date of 2023-11-09 and a creation date of 2023-09-08. The award ceiling is listed as $250,000. The listing shows "ExpectedAwards:" without a number, suggesting the expected number of awards was not specified in the provided source excerpt. Overall, the grant is aimed at building the data coordination backbone for a research effort that can produce better models of preteen suicide risk, clarify what protects children from progressing toward self-harm and attempts, and deliver measurement approaches that are practical and informative for real-world prevention and clinical use.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Data Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2023-09-08.
  • Applicants must submit their applications by 2023-11-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $250,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA MH 24 322

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is this NIH funding opportunity?

This opportunity is an NIH cooperative agreement to establish and operate a Data Coordinating Center (DCC) that supports a research initiative focused on identifying preteen suicide risk and protective factors. The opportunity is listed as RFA-MH-24-322 under CFDA 93.242 in the health funding category.

What funding mechanism is being used?

The mechanism is a U24 cooperative agreement (clinical trial not allowed). A cooperative agreement typically means NIH expects substantial programmatic involvement during the award, with a strong emphasis on coordination and shared infrastructure.

Are clinical trials allowed under this opportunity?

No. This is a U24 (clinical trial not allowed). The overarching purpose is to support coordinated, data-driven research efforts rather than to run clinical trials.

What is the primary purpose of the Data Coordinating Center (DCC) in this initiative?

The DCC is intended to provide the data coordination backbone for the broader research initiative. This commonly includes harmonizing data collected across participating projects, ensuring high-quality data management and documentation, enabling secure data transfer, and making data usable for analyses that address preteen suicide risk and protective factors.

What kinds of scientific questions is the initiative trying to address?

The initiative emphasizes improving how the field understands and predicts suicide-related outcomes in preteens, including how risk emerges, changes over time, and could become actionable for prevention. A central focus is on modeling "risk states" and understanding how those states transition into observable risk behaviors such as self-harm and suicide attempts.

What does NIH mean by moving beyond broad, static risk indicators?

The opportunity highlights a need for models that do more than list general correlates or unchanging risk markers. It points toward characterizing patterns and trajectories of risk, identifying near-term warning signs, and distinguishing underlying vulnerability from periods of acute or escalating risk.

What are "risk states" in the context of this opportunity?

Based on the description, "risk states" refer to potentially identifiable conditions or periods that reflect varying levels or forms of suicide risk in preteens. The initiative is interested in understanding how these states appear, how they change over time, and how they may progress into observable risk behaviors.

What types of outcomes or behaviors are specifically mentioned?

The opportunity explicitly references suicide-related outcomes in preteens, including self-harm and suicide attempts, as examples of observable risk behaviors that models should help explain and predict.

What is meant by identifying protective factors?

The initiative aims to identify protective factors that reduce risk or help prevent progression toward self-harm or suicide attempts. It highlights both proximal protective factors (near-term buffers) and distal protective factors (longer-term influences on resilience and developmental pathways).

What is the difference between proximal and distal protective factors in this opportunity?

Proximal protective factors are described as near-term buffers that may reduce risk in the short run (for example, immediate supports, coping resources, or family and school-based protective conditions). Distal protective factors are described as factors that may shape longer-term resilience and developmental pathways.

Why does the opportunity emphasize "modifiable" protective factors?

The opportunity highlights protective factors that are measurable and potentially modifiable, meaning they could be strengthened or enhanced and used as practical levers for prevention strategies rather than remaining purely descriptive variables.

Does the initiative address intervention targets and timing?

Yes. A stated goal is to pinpoint intervention targets and the timing of intervention, along with scalable assessment approaches that have clinical utility.

What does "scalable assessment" mean in this context?

"Scalable assessment" refers to measurement approaches that can be implemented broadly and efficiently in real-world settings. The description points to use in pediatric clinics, schools, community programs, and other youth-serving systems.

What does "clinical utility" mean in this context?

"Clinical utility" signals that assessment outputs should be useful in real settings to characterize risk and protective factors in ways that support prevention-related actions, such as screening, monitoring, triage, referral, or similar steps.

What role does a U24 DCC typically play in a consortium like this?

The opportunity describes a DCC role that commonly includes leadership on data governance, common data elements, documentation, secure data transfer, database design, analytic support, and facilitation of collaboration across the broader research consortium.

How does a cooperative agreement differ from a standard research grant for this project?

Compared with a standard research grant, the cooperative agreement structure indicates stronger expectations around coordination, shared infrastructure, data standards, governance processes, and responsiveness to NIH program priorities, with substantial NIH programmatic involvement during the award.

Who is eligible to apply?

Eligibility is broad and includes: state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations (other than small businesses); and small businesses.

Are any additional organization types specifically called out as eligible?

Yes. The notice also calls out Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; and U.S. territories or possessions.

Are non-U.S. (foreign) entities eligible to apply?

No. The opportunity excludes non-domestic (non-U.S.) entities. Foreign organizations are not eligible.

Are foreign components allowed as part of an application from a U.S. organization?

No. The opportunity states that non-domestic components of U.S. organizations and foreign components (as defined in NIH policy) are not allowed.

What is the award ceiling for this opportunity?

The award ceiling is listed as $250,000.

How many awards does NIH expect to make?

The provided listing shows "ExpectedAwards:" without a number. Based on the provided information excerpt, the expected number of awards is not specified.

What are the key dates mentioned in the opportunity description?

The creation date is listed as 2023-09-08, and the original closing date is listed as 2023-11-09.

What is the overall intent of the initiative that the DCC will support?

The overall intent is to build coordinated, harmonized data resources and analytic readiness for research that produces better models of preteen suicide risk, clarifies protective factors that may prevent progression toward self-harm and attempts, and supports measurement approaches that are practical and informative for real-world prevention and clinical use.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Farm Labor Stabilization and Protection Pilot Program

Previous opportunity: Grants for Adaptive Sports Programs for Disabled Veterans and Members of the Armed Forces program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MH 24 322

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MH 24 322) also looked into and applied for these:

Funding Opportunity
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) Apply for PAR 23 300

Funding Number: PAR 23 300
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 056

Funding Number: RFA AI 23 056
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed) Apply for RFA RM 23 017

Funding Number: RFA RM 23 017
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Program (HVP) (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 016

Funding Number: RFA RM 23 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,875,000
Human Virome Characterization Centers (U54 Clinical Trial Not Allowed) Apply for RFA RM 23 019

Funding Number: RFA RM 23 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed) Apply for RFA RM 23 018

Funding Number: RFA RM 23 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for PAR 23 305

Funding Number: PAR 23 305
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Apply for PAR 23 307

Funding Number: PAR 23 307
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 332

Funding Number: RFA MH 24 332
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required) Apply for RFA MD 24 003

Funding Number: RFA MD 24 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) Apply for PAR 23 301

Funding Number: PAR 23 301
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) Apply for PAR 23 302

Funding Number: PAR 23 302
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 054

Funding Number: RFA AI 23 054
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) Apply for RFA DE 24 006

Funding Number: RFA DE 24 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $650,000
Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) Apply for PAR 23 221

Funding Number: PAR 23 221
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 24 037

Funding Number: PAR 24 037
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) Apply for PAR 23 228

Funding Number: PAR 23 228
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Development and Renovation of Facilities for Expanding the Breeding Capacity of Specific Pathogen Free Non-Human Primates to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed) Apply for PAR 24 033

Funding Number: PAR 24 033
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 23 306

Funding Number: PAR 23 306
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) Apply for RFA AI 23 057

Funding Number: RFA AI 23 057
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 24 322", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: